Article
Oxidative cleavage of premithramycin B is one of the last steps in the biosynthesis of the antitumor drug mithramycin.
Chemistry & biology - 1 Jan 1999
Prado L, Fernández E, Weissbach U, Blanco G, Quirós L M, Braña A F, Méndez C, Rohr J, Salas J A
Abstract excerpt
BACKGROUND: Mithramycin is a member of the clinically important aureolic acid group of antitumor drugs that interact with GC-rich regions of DNA nonintercalatively. These drugs contain a chromophore aglycon that is derived from condensation of ten acetate units (catalyzed by a type II polyketide synthase). The aglycones are glycosylated at two positions with different chain length deoxyoligosaccharides, which are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
